Purdue Pharma – MOSAEC

Ex-McKinsey Partner Sentenced in Obstruction Case

The consultant had deleted records involving McKinsey’s role in pushing OxyContin sales and driving the opioid crisis.

By Michael Forsythe

Bankruptcies Compensation for Damages (Law) James, Letitia New York State Opioids and Opiates Purdue Pharma Sackler Family States (US) Suits and Litigation (Civil) Supreme Court (US) United States

Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition

A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars from the settlement in a legal-defense fund for the family.

By Jan Hoffman

CVS Caremark Corporation Drugs (Pharmaceuticals) Express Scripts Inc Health Insurance and Managed Care Mallinckrodt Pharmaceuticals Opioids and Opiates Optum Inc OxyContin (Drug) Pain-Relieving Drugs Purdue Pharma Rebates and Refunds

Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.

By Chris Hamby

Compensation for Damages (Law) Food and Drug Administration Justice Department McKinsey & Co Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Purdue Pharma Sagar, Vikas

McKinsey to Pay $650 Million in Opioid Settlement With Justice Department

A senior partner has also pleaded to obstruction of justice after destroying company documents.

By Walt Bogdanich and Michael Forsythe